IRVAX | VIVIX | IRVAX / VIVIX | |
Total Expense Ratio | 0.84 | 0.04 | 2,100% |
Annual Report Gross Expense Ratio | 0.94 | 0.04 | 2,350% |
Fund Existence | 10 years | 27 years | - |
Gain YTD | -12.925 | 6.730 | -192% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 278M | 195B | 0% |
Annual Yield % from dividends | 7.19 | 2.19 | 328% |
Returns for 1 year | -9.52 | 9.75 | -98% |
Returns for 3 years | 11.50 | 34.32 | 34% |
Returns for 5 years | 42.07 | 74.87 | 56% |
Returns for 10 years | 61.32 | 116.26 | 53% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SPMIX | 26.25 | 0.24 | +0.92% |
Shelton S&P Midcap Index Investor | |||
LVOPX | 18.03 | 0.16 | +0.90% |
Lord Abbett Value Opportunities P | |||
ICIEX | 23.73 | 0.11 | +0.47% |
Macquarie Core Equity Fund Class I | |||
AYBLX | 11.82 | 0.04 | +0.34% |
Victory Pioneer Balanced Y | |||
RIRGX | 77.67 | -0.04 | -0.05% |
American Funds Capital Income Bldr R6 |